In human cardiac ventricle, I K1 is mainly comprised Kir2.1, but Kir2.2 and Kir2.3 heterotetramers occur and modulate I K1 . Long-QT syndrome-9-associated CAV3 mutations cause decreased Kir2.1 current density, but Kir2.x heterotetramers have not been studied. Here, we determine the effect of long-QT syndrome-9-CAV3 mutation F97C on Kir2.x homo-and heterotetramers and model-associated arrhythmia mechanisms.
I
n the human cardiac ventricle, I K1 maintains the resting membrane potential and contributes to phase 3 repolarization. 1 The inward rectifier potassium channel Kir2.1 subunits, encoded by KCNJ2, assemble in tetramers and are the major molecular correlate of I K1 . Gain-or loss-of-function mutations in KCNJ2 cause genetic sudden cardiac death syndromes, [2] [3] [4] and loss of functional I K1 is a major contributing factor to arrhythmogenesis in failing human hearts. 5 Kir2.x family members Kir2.2 and Kir2.3 can create heterotetramers with Kir2.1 in the heart, whereas Kir2.x family member Kir2.4 has only been found in neural tissue associated with the heart. 6,7 Kir2.1, Kir2.2, and Kir2.3 contribute to I K1 in chamber-specific ratios that change during development, with ventricle upregulation of Kir2.1 and Kir2.2 and downregulation of Kir2.3. 8, 9 Homotetrameric Kir2.x channels have distinct biophysical properties, including single channel conductance, pH sensitivity, strength of rectification, and response to specific agonists. [10] [11] [12] However, Kir2.x in heterotetramers can transfer their properties or can acquire the properties of the other channel isomers. For example, pH-sensitive Kir2.3 combined with strong rectifier Kir2.1 in heterotetrameric channels create pH-sensitive strongly rectifying channels. 11 The degree to which Kir2.x heteromerization affects arrhythmogenesis in sudden death syndromes has not been investigated.
Caveolae are lipid microdomains characterized by the presence of Cav3 that serve to localize proteins
WHAT IS KNOWN?
• Kir2.1, Kir2.2, and Kir2.3 are the molecular correlates of I K1 in the heart. • Long-QT syndrome-9 is caused by CAV3 mutations.
• F97C-Cav3 mutation increase late sodium current (I NaL ) and decreases Kir2.1 current density by distinctive mechanisms.
WHAT THE STUDY ADDS?
• Kir2.x isoforms have a unique intracellular pattern of distribution in association with Cav3.
• Long-QT syndrome-9-causing CAV3 mutation differentially regulates current density and cell surface expression of Kir2.x homomeric and heteromeric channels.
• Mathematical Purkinje cell and myocyte models suggest that both loss of I K1 and increased I NaL are required for arrhythmia generation in long-QT syndrome-9.
and regulatory elements for protein signaling activity. 13 Cav3 is encoded by CAV3, and mutations in CAV3 can cause cardiac diseases, including long-QT syndrome-9 (LQT9). 14 In addition, abnormal distribution or density of Cav3 is implicated in atrial fibrillation and ventricular arrhythmias in heart failure. 15, 16 Our laboratory has previously shown that CAV3 mutations associated with LQT9 increase late sodium current (I NaL ), decrease Kir2.1 current density, and predispose to sudden arrhythmic death. 17, 18 Cav3 has 4 distinct domains: N-terminal, scaffolding, membrane, and C-terminal domains. 13 Interestingly, most of the LQT9-associated CAV3 mutations exist in the membrane domain of Cav3 protein, raising the question as to whether this specific domain of Cav3 may be critical for its role affecting ion channels. Kir2.x isoforms contain several possible Cav3-binding motif (CBM) sites composed of a specific series of amino acids QxQxxxxQ or QxxxxQxxQ or QxQxxxxQxxQ, where Q is an aromatic amino acid residue and an x represents any other residue. 19 The site that most closely matches a CBM because of accessibility for Cav3 binding on an exposed portion of the folded Kir2.x protein 20, 21 lies between amino acids 81 and 92 for Kir2.1. However, important details of molecular interaction between Cav3 and Kir2.x have not been elucidated. 22 In our studies using induced pluripotent stem cellderived cardiomyocytes, LQT9 CAV3 mutation, F97C-Cav3, resulted in action potential (AP) prolongation and early-after depolarizations (EADs) because of both loss of Kir2.1 and an increased I NaL . 23 One arrhythmia mechanism related to LQT9 may be development of EAD triggered activity, which in the whole organ can result in Torsade de Pointes and sudden arrhythmic death. 24 However, loss of I K1 has also been linked to delayed after-depolarization (DAD)-driven ventricular arrhythmia. 25, 26 Purkinje cells have both a high density of caveolae 27 and are known to be important drivers of arrhythmogenicity, 28 and we suspect that Purkinje cells may be particularly sensitive to Cav3 mutations. Thus, to understand the complex physiological interaction between Kir2.x homo-and heterotetramers and Cav3 and the pathophysiologic arrhythmogenic implications of LQT9-CAV3, here we investigate (1) immunocolocalization and immunoprecipitation of Kir2.2 and Kir2.3 with Cav3 in native human tissue and in heterologous cells, respectively, (2) Förster resonance energy transfer (FRET) efficiency of Kir2.x and Cav3, (3) the impact of LQT9-causing CAV3 mutation on Kir2.x current as homo-or heterotetramers and on Kir2.x protein trafficking, (4) critical Cav3 protein domains required for interaction with Kir2.x channels and the details of the Kir2.x CBM Cav3 association, and (5) incorporate our electrophysiological data to model the consequences of I K1 and I NaL changes because of LQT9 CAV3 mutation using computational models of ventricular and Purkinje cells.
METHODS

Experimental Procedures
Ethical Approval
All experiments were conducted in accordance with the University of Wisconsin-Madison and conform to National Institutes of Health guidelines. Human tissue was obtained from the University of Wisconsin human tissue bank and approved by the University of Wisconsin-Madison Institutional Review Board 2011-0194.
The data, analytic methods, and study materials will be made available on request to other researchers for purposes of reproducing the results or replicating the procedures.
Cav3, KCNJ4, and KCNJ12 Construction and Mutagenesis
The wild-type (WT) human CAV3 456-bp coding sequence was cloned from human cardiac cDNA. 17 Site-directed mutagenesis was performed with the QuikChange Site-Directed Mutagenesis Kit (Stratagene) using the vector containing the Cav3-WT inserts as a template. Human KCNJ4 (Kir2.3) and KCNJ12 (Kir2.2) clone was previously created and reported in this laboratory. 29 Insertion of hemagglutinin (HA)-tag Kir2.2 extracellular residue 118 was performed using via standard cloning techniques via Geneblock (IDT) with restriction sites AfeI and ClaI. Kir2.1 and Kir2.2 N-terminus (NT) and C-terminus (CT) domains were created using amplicons for Kir2.1/Kir2.2. NT and CT from polymerase chain reactions (PCR) were ligated into the PCR2.1 topo vector. The NT and CT domains were excised out of the PCR2.1 vector and ligated using NT-GFP (green fluorescent protein) pcDNA3.1 Topo vector. PCR, bacterial transformation, and cloning were performed according to manufacturer's instructions. The Cav3 domains were constructed using primers previously described. 30 Briefly, the amplicons were generated and cloned into pcDNA3.1 Topo vector via restriction sites HindIII and XbaI containing a Hexa-His tag and a V5 tag at the C-terminal. An NT mCherry was added to the above Cav3 domain construct using BamHI and HindIII restriction site. Kir2.x dimers (Kir2.2/ Kir2.3 and Kir2.2/Kir2.1) were created with a self-cleaving P2A peptide sequence ((GSG) A T N F S L L K Q A G D V E E N P G P) in the middle (Vectorbuilder.com). All constructs cloned or subcloned were sequenced and confirmed for correct sequence or mutagenesis. See Table I in the Data Supplement for list of primers and constructs.
Cell Culture and Transfections
We chose human embryonic kidney 293 (HEK293) cells because of their lack endogenous caveolins. HEK293 cells were cultured in DMEM (Invitrogen) with 10% fetal bovine serum. HEK293 cells were transiently transfected using Fugene 6 (Promega) per the manufacturer specifications. For electrophysiological experiments, an equal amount of WT or mutant Cav3 (Pires-EGFP, Clonetech, Palo Alto, CA) along with homotetrameric Kir2.x (pcDNA3.1) were used for electrophysiology experiments. For experiments with heterotetrameric Kir2.x dimer constructs and WT or mutant Cav3 (Pires-EGFP, Clonetech, Palo Alto, CA), a 1:3 ratio of Kir2.x dimer Cav3(WT/mutant) was used.
Immunostaining
Human left ventricular tissue was obtained from the University of Wisconsin tissue bank and prepared for immunostaining as described previously. 11 The rabbit anti-Kir2. 
Co-Immunoprecipitation
HEK293 cells transfected with plasmids of interest were homogenized in ice-cold radioimmunoprecipitation assay buffer (25 mmol/L Tris-HCl [pH 7.4], 150 mmol/L NaCl, 60 mmol/L n-octyl d-glucoside, 1% Triton X-100, 2 mmol/L phenylmethylsulfonyl fluoride, and a protease inhibitor tablet/50 mL). The homogenate was centrifuged at 100×g to remove insoluble debris. A total of 4 to 8 mg of precleared cell was used for each reaction. Lysates were incubated in primary antibody overnight at 4°C, and protein-antibody complexes were recovered using recombinant protein A/Gsepharose (Pierce or Santa Cruz) beads. The isotype control IgG was used as a negative control. Cell lysates were separated on precast 10% to 20% SDS-PAGE gels and immunoblotted as described previously.
11
Electrophysiology
Transfected HEK cells' membrane currents were analyzed 24 to 48 hours after transfection using whole-cell technique . Control experiments WT-Cav3 were done contemporaneously with the F97C-Cav3 mutation. Cells were identified by GFP fluorescence. Starting at a holding potential of −50 mV, voltages were ramped from −120 to 20 mV at 25mV/s. Data were filtered at 5 kHz and digitized using a Digidata 1400 (Axon Instruments). Analysis of data was done using pClamp10 (Axon Instruments) and Origin 8 software (OriginLab Corporation).
On-Cell Western Analysis
Monolayers of HEK293 cells transiently cotransfected with HA-Kir2.2 and Cav3-WT or Cav3-F97C were fixed 22 to 24 hours after plating with 4% paraformaldehyde. Cells were washed with 1× PBS and then blocked with 5% normal goat serum made in 1× PBS for an hour and then incubated with mouse anti-HA antibody for 90 minutes. Cells were incubated in IRDye-680 goat anti-mouse secondary antibody for an hour. Control cells (blank HEK293) were only incubated with secondary antibodies and no primary antibody. Cells were imaged according to manufacturer specification (Li-cor Biosciences, Lincoln, NE). Integrated intensities of the 700-nm infrared signal for each well were calculated using Li-Cor Odyssey infrared imaging system software. Background intensity was subtracted from the experiment, and results are reported as normalized data.
18,32
Acceptor Photobleaching FRET
FRET by acceptor photobleaching 33, 34 was performed using a Leica TCS SP5 confocal microscope outfitted with a Leica inverted microscope, an argon laser, and 40X1.3 numeric aperture plan apochromatic oil immersion objective (Exton, PA). Live samples were imaged within 48 hours after transfection. The donor (GFP) was excited at 488 nm and emission collected from 492 to 505 nm, and the acceptor (mCherry) was excited at 561 nm and emission collected from 570 to 696 nm. FRET was measured by the acceptor photobleaching method and analyzed using Leica analysis software. FRET efficiency (E) was calculated using Leica software: E=(D post −D pre )/D post , where D pre and D post are GFP emissions before and after regional photobleaching. To calculate the distance between molecules (r), we used the following formula: FRET efficiency=(ro) 6 /((ro)6+(r) 6 ) where ro=5.24 nmol/L. 34 
Mathematical Modeling and Simulation
The human ventricular AP was simulated with both the Grandi-Pasqualini-Bers 35 (code available for download at https://somapp.ucdmc.ucdavis.edu/Pharmacology/bers/ or http://elegrandi.wixsite.com/grandilab/downloads) and the O'Hara-Rudy (http://rudylab.wustl.edu/research/cell/code/ AllCodes.html) models. 36 The O'Hara-Rudy formulation of I NaL was introduced in the Grandi-Pasqualini-Bers model. 35 All simulations were performed in MATLAB (The MathWorks, Natick, MA) using the stiff ODE solver ode15s. The canine Purkinje cell AP was simulated using the Li-Rudy 37 coded in C++ (http://rudylab.wustl.edu/research/cell/code/AllCodes. html). The rapid integration numeric technique was used to solve the system of ordinary differential equations, with minimum and maximum integration steps of 0.001 and 0.1 ms, respectively. Simulations were run to steady state.
Statistical Analysis
Data are expressed as mean±SEM unless specified otherwise and analyzed using either an unpaired Student t test or ANOVA using Microsoft Excel. Values of P<0.05 were considered significant.
RESULTS
Human Ventricular Tissue Kir2.x Localization Pattern and Immunocolocalization With Cav3
Human left ventricular cryopreserved tissue sections were immunostained with Kir2.1, Kir2.2, Kir2.3, and Cav3. Images were acquired on a super-resolution STED Leica SP8 confocal microscope. Shown in Figure 1A 
Kir2.x Channels Coimmunoprecipitate With WT and LQT9 Cav3 Mutation
Co-immunoprecipitation (Co-IP) and Western blot analysis were performed for HEK293 cells trans- 
Kir2.x Homomeric Channel Currents Are Differentially Modulated by LQT9 Cav3 Mutation
In a previous study, we found that the LQT9-associated CAV3 mutation F97C-Cav3 decreased Kir2.1 current density, but WT-Cav3 had no effect on Kir2.1 current compared with control without Cav3. 33 Because human ventricular I K1 also contains Kir2.2 and to a lesser degree Kir2.3, we studied the effect of F97C-Cav3 or WT-Cav3 on Kir2.2 or Kir2.3 when coexpressed in HEK293 cells. A sample trace of Kir2.2 current with WT-Cav3 or F97C-Cav3 using ramp protocol from −120 to +20 mV at 25mV/s is displayed in Figure 2A . Summary data of the Kir2.2 and Kir2.3 relationships with WT-Cav3 or F97C-Cav3 are illustrated in Figure 2B and 2C, respectively, and quantitatively in Table 1 . Average peak outward (−40 mV) and inward (−120 mV) Kir2.2 current density was decreased when expressed with F97C-Cav3 compared with WT-Cav3, P<0.01. In contrast, neither peak outward (−40 mV) nor inward (−120 mV) Kir2.3 current density was different between cells with either WT-Cav3 or F97C-Cav3, P>0.05.
Cav3 and Kir2.2 Association by FRET
We studied the association of Kir2.2 and Cav3 by FRET using the acceptor photobleaching method. We designed Kir2.2 as the donor with N-terminal GFP and Cav3 as acceptor with N-terminal mCherry. HEK293 cells were transfected with Kir2.2-GFP and Cav3-mCherry versus vector-mCherry (as the negative control). Prebleached, live cells expressing both fluorophores were chosen for study, and regions of interest were selected at the cell membrane, representative images shown in Figure I in the Data Supplement. Kir2.2 and Cav3 FRET efficiency is 25.0±1.76% versus 6.86±1.05% for Kir2.2 and vector alone (P<0.0001). Summary results are shown by the bar graph in Figure 3A . The calculated distance between proteins based on FRET efficiency is 6.61 NM.
CAV3 Mutation Decreases Cell Surface Expression of Kir2.2 Channels
We previously found that Kir2.1 surface membrane expression decreases in the presence of F97C-Cav3. 18 As shown in Figure 3 , Kir2.2 but not Kir2.3 current density was affected by F97C-Cav3. Therefore, we studied Kir2. by 53.7±4.8%, but WT-Cav3 showed no difference (107±4.8%) from control experiment (n=8; P<0.001). A representative example of on-cell Western blotting technique is shown in Figure 3C . Figure II in the Data Supplement).
Heterotetrameric Channels Kir2.1-Kir2.2 and Kir2.3-Kir2.2 Remain Susceptible to F97C-Cav3
Heterotetrameric channels containing combinations of Kir2.1, Kir2.2, or Kir2.3 exist in the heart. To understand the physiological consequences of Kir2.x combinations in the presence of LQT9-associated CAV3 mutation F97C, particularly given the differential effect on homomeric channels (Figure 2) , we studied Kir2.1-Kir2.2 or Kir2.2-Kir2.3 dimer constructs transfected with WTCav3 versus F97C-Cav3. Example barium sensitive traces recorded using the ramp protocol are shown in Figure 4A for Kir2.1-Kir2.2 and Figure 4C for Kir2.2-Kir2.3. Ramp protocol is depicted in the inset in the same panels. Summary data of the Kir2.1-Kir2.2 relationship with WT-Cav3 or F97C-Cav3 are illustrated in Figure 4B and in Table 2 . Average peak outward (−50 mV, Figure 4B inset) and inward (−120 mV) Kir2.1-Kir2.2 dimer current with F97C-Cav3 was decreased compared with WT-Cav3, P<0.05. Despite the lack of F97C-Cav3 on Kir2.3 monomers, both peak outward (−60 mV, Figure 4D inset) and inward (−120 mV) Kir2.2-Kir2.3 dimer current decreased in the presence of F97C-Cav3 compared with WT-Cav3, shown in Figure 4D and summarized in Table 2 , P<0.05. 19 This potential CBM is conserved across isoforms, as depicted in Figure 5E . 38 In previous studies, the Kir2.1 Golgi export signal requires association of critical NT and CT residues. 39 In addition, we previously found that F97C-Cav3 caused accumula- tion of Kir2.1 in the Golgi, 33 and here we find decreased Kir2.2 trafficking in the presence of F97C-Cav3. Thus, there may be disruption of the Golgi export signal in the presence of F97C-Cav3. To determine the critical region for Cav3 and Kir2.x interaction, we created HA-tagged constructs containing the intracellular CBM for Kir2.1 and Kir2.2 (see Table I in the Data Supplement for construct primer details). HEK293 cells were cotransfected with Cav3 and 1 of the 4 constructs: HA-Kir2.1-NT, HAKir2.1-CT, HA-Kir2.2-NT, or HA-Kir2.2-CT. Cell lysates were analyzed by Western blot as shown in Figure 5A and 5C, left panels. The co-IP demonstrates that HAKir2.2-NT associates with Cav3 but not HA-Kir2.2-CT or IgG (negative control; Figure 5A , right panel), indicated by arrow heads. Similarly, HA-Kir2.1-NT, but not HA-Kir2.1-CT or IgG, co-IPs with Cav3 ( Figure 5C , right panel), indicated by arrow heads. This suggests that for both Kir2.2 and Kir2.1, the NT CBM is necessary for interaction with Cav3. Figure 5D , left panel for Kir2.1 with Cav3 or its domains. Co-IP analysis shown in Figure 5B , right panel, for Kir2.2 (n=5) and Figure 5D , right panel, for Kir2.1 (n=4), demonstrates the Cav3-scaffolding and Cav3-membrane domains associate with Kir2.2 and Kir2.1 while the NT and CT Cav3 domains do not associate with either Kir2.2 or Kir2.1. 
Implications for Arrhythmogenesis
We sought to determine the consequences of Cav3-mediated Kir2.x downregulation and I NaL enhancement for arrhythmia triggers by simulating human ventricular and canine Purkinje cell computational models. [35] [36] [37] To elicit EADs, we reduced the repolarization reserve by pacing the virtual cells at slow rates (4000 and 2000 ms basic cycle length [BCL]). DAD occurrence was assessed after rapid pacing (300 ms BCL) and subsequent pause after pacing cessation.
With both the Grandi-Pasqualini-Bers 35 and O'HaraRudy 36 human ventricular cell models, increase of I NaL and I K1 reduction result in AP prolongation, especially at slow rates, but EADs are only seen when the maximal conductance of I NaL is increased by several fold. As shown in Figure 6A , a 12-fold increase in I NaL causes EAD in the Grandi-Pasqualini-Bers model paced at 4000 ms. In this setting, I K1 reduction depolarizes the resting membrane potential and reduces I Na , thus relatively decreasing I NaL availability and counteracts the formation of EADs. We obtained the same results when simulating a condition in which I K1 is carried by the Kir2.1 isoform only (ie, not by a mix of isoforms; see Figure 6C ). However, with the single isoform, a greater reduction of I K1 is required to prevent EADs ( Figure 6B ). Similar results were predicted at faster pacing rates (basic cycle length=2000 and 1000 ms). In the O'HaraRudy model, a much larger increase in I NaL is needed to elicit EADs, and I K1 downregulation has little effect on EAD formation but prolongs final repolarization (data not shown). No DADs are elicited in the human ventricular cell models with the described changes in I K1 and I NaL densities (data not shown).
In contrast, using the Li-Rudy canine Purkinje cell model, 37 triggered activity is readily revealed when simulating concomitant I K1 downregulation (−50%) and I NaL upregulation (2-fold increase). In Figure 7 we demonstrate the Li-Rudy Purkinje model showing simulated AP (top panels), calcium transient (middle panels), and sodium-calcium exchange activity (lower panels). At slow pacing rate (both 4000 and 2000 ms BCL), spontaneous APs are generated between paced APs ( Figure 7A and 7D) , via a mechanism involving I NaL -induced calcium loading, calcium release, and consequent sodium-calcium exchange enhancement leading to resting membrane potential depolarization. This dual effect of calcium loading and unstable resting membrane potential increases the likelihood of calcium overload-mediated diastolic calcium release and decreases the threshold for DADs as shown in Figure 7 . Notably, blocking I f does not prevent the occurrence of unstimulated beats. At faster pacing rates, under control conditions or with 50% I K1 reduction alone, no triggered activity is observed, and with 50% I K1 reduction, there is slight resting membrane potential depolarization ( Figure 8A and 8B) . When simulating I NaL upregulation (+100%) alone, DADmediated triggered activity is predicted causing a few unstimulated beats before returning to a stable resting membrane potential ( Figure 8C) . Notably, when concomitant I K1 downregulation and I NaL enhancement are combined, as is the hypothesized effect of F97C-Cav3 mutation, the synergistic interaction of increasing calcium load and reducing DAD threshold lead to AP oscillations, which are not prevented by I f inhibition ( Figure 8D and 8E) . 
DISCUSSION
We demonstrated the differential and protein domainspecific distribution of Kir2.x channels in association with Cav3 and explore the impact on Kir2.x homomeric and heteromeric channel current densities when expressed with LQT9-associated CAV3 mutation. We have then combined these findings and our previously established current changes with LQT9 CAV3 mutation and incorporated these into a mathematical Purkinje and ventricular myocyte models. Colocalization of Kir2.1 at the sarcolemma, intercalated disc, and T-tubules with Cav3 and Kir2.2 at T-tubules by STED correlates with the vulnerability of Kir2.1 and Kir2.2 when expressed with a LQT9 CAV3 mutation. Our mathematical modeling suggests an unexpected arrhythmia mechanism for an LQT mutation, but one that is consistent with loss of I K1 .
Differential Human Ventricular Intracellular Distribution of Kir2.x
Kir2.x isoforms have differential distribution in cardiac tissue, 8 and we show here their intracellular relationship in human ventricular tissue in association with Cav3. Kir2.1 is the dominant isoform and colocalizes with Cav3 by STED super-resolution microscopy to the sarcolemma, T-tubule, and intercalated disc. There seems to be overlapping distribution of Cav3 and Kir2.1 with Kir2.2 in the T-tubule and with Kir2.3 at the intercalated disc. Although similar Kir2.x distribution patterns have been noted in the canine ventricle, 40 to our knowledge, this is the first detailed description in human ventricular tissue. Interestingly, we did not see an overlap of Kir2.2 and Kir2.3 despite previous work demonstrating function heterotetramers of these isoforms. 11 Note that we did not analyze human atrial tissue, where there is relatively more Kir2.3. 8 The lack of effect of F97C-Cav3 on Kir2.3 may be one explanation for the absence of atrial arrhythmias in these patients with CAV3 mutations. Given the intracellular distribution of Kir2.1 and Kir2.2, and our finding of loss of function of Kir2.1 18 and Kir2.2 in the presence of CAV3 mutations, we propose that ventricular myocytes have disrupted caveolar membrane domain presence of inward rectifier current and subsequent arrhythmia vulnerability.
Cav3 creates cellular microdomains to efficiently compartmentalize ion channels, G-protein-coupled receptors, and regulatory proteins. Disruption of those microdomains can result in ion channel dysfunction and arrhythmogenesis. The disruption of Kir2.1 and Kir2.2 in caveolar membranes may also be proarrhythmic for other clinical entities, including dilated cardiomyopathy. Kir2.x isoforms change expression patterns in dilated cardiomyopathy, 41 and Cav3 has been shown to be downregulated. 13 Namely, Kir2.1 and Kir2.3 proteins and transcripts increase while Kir2.2 is downregulated 41 despite overall loss of I K1 .The loss of caveolar membrane in heart failure results in dysregulation of the l-type calcium channel. 42, 43 Overall, we suspect that one of the mechanisms involved in l K1 loss in heart failure is related to the loss of caveolar membranes causing abnormal distribution or failure to traffic of Kir2.1 and Kir2.2, leading to loss of repolarization reserve and arrhythmogenesis. This is an active area of research in our laboratory, and the current study supports this hypothesis.
Cav3 Domain Specificity of Kir2.x Interaction
Mutations in CAV3 cause a range of degenerative muscular disorders in skeletal muscle, including limb-girdle muscular dystrophy autosomal dominant type C, isolated hyperCKemia, rippling muscle disease, and distal myopathy. 44 In the heart, CAV3 mutations are associated with hypertrophic cardiomyopathy and LQTS, so-called LQT9. 17, 44 Of the known mutations related to caveolinopathies, the majority are in the highly conserved scaffolding domains 45 while in LQT9, the majority are in the scaffolding and membrane domains. Here, we find that the scaffolding and membrane Cav3 domains interact (indirectly or directly) with Kir2.1 and Kir2.2. This is intriguing from a pathophysiology perspective given that LQT9 mutations most often occur in these Cav3 domains. This raises the question as to whether this Cav3-specific domain may be critical for its role affecting ion channels versus degenerative muscular disorders, however will require additional sequence analyses for LQT and other genetic cardiac disorders.
Kir2.1 and Kir2.2 Cav3-Binding Sequence Homology and Protein Trafficking
Despite their unique properties and regulation, both Kir2.1 and Kir2.2 have sequence homology with Cav3-binding motifs. We determined that the N-terminal Cav3-binding motif is required for interaction of both Kir2.1 and Kir2.2. In our previous work, we found that the F97C mutation caused disruption of Kir2.1 surface membrane expression with retention of protein in the Golgi. 18 For Kir2.1, the Golgi export signal involves conserved basic residues from the NT and hydrophobic CT residues which interact to form a salt-bridge patch of residues to form the AP-1 (adaptor protein complex-1) binding signal for sarcolemma distribution. 39, 46 We suspect that F97C-Cav3 disrupts the salt bridge formation in normal NT residues association of Kir2.1 or Kir2.2. This interferes with AP-1-binding signal formation and thus loss of protein at the surface membrane. Alternatively, the NT Cav3-binding motif overlaps with the cholesterol sensitivity belt, 47, 48 and F97C-Cav3 may disrupt the membrane channel insertion because of lack of capability to bind cholesterol. It is unclear whether Cav3 and cholesterol independently regulate Kir2.x membrane localization or whether these mechanisms combine in cardiomyocytes to regulate Kir2.x channel distribution and function.
Loss of I K1 and Increase in I NaL in LQT9: Vulnerable Sink With Arrhythmogenic Source
Loss of Kir2.1 and Kir2.2, whether as homo-or heterotetramers, can lead to decreased membrane stability and AP prolongation in the ventricle. In our previous studies, we have evaluated the impact of an LQT9 CAV3 mutation on Kir2.1 current, 18 and here we demonstrate not only the impact of the mutation on Kir2.2 current, the Kir2.x isoform also commonly found in human ventricular myocytes, but also on Kir2.3. Interestingly, Kir2.3 current was not affected by LQT9 CAV3 mutation, but the heterotetramer Kir2.2-Kir2.3 demonstrated loss of function. This highlights the importance of the Kir2.1/Kir2.2-Cav3 relationship in the ventricle and the potential for arrhythmogenesis.
The signature arrhythmia in LQTS is Torsade de Pointes, which occurs in the setting of decreased repolarization reserve and susceptibility for EADs. 49 Unlike genetic arrhythmia syndromes related to an ion channel mutation, LQT9 and other channel-associated proteins can affect >1 channel or regulatory pathway. As such, another arrhythmogenic factor for LQT9 CAV3 mutations is an increase in I NaL 17 by channel nitrosylation. 50 Taken together, loss of I K1 and increase in I NaL can decrease repolarization reserve and cause AP prolongation and EADs in induced pluripotent stem cellderived cardiomyocytes. 23 When combining the effects of F97C-Cav3 on both I K1 and I Na , we hypothesized a mechanism of EAD-induced triggered activity for arrhythmogenesis. The mathematical myocyte modeling revealed I NaL -associated EADs in myocytes (opposed by I K1 downregulation) but no sustained arrhythmic activity, similar to our induced pluripotent stem cellderived cardiomyocyte experiments. 23 Interestingly, the Purkinje model revealed a DAD-driven triggered activity and sustained arrhythmia. Taken in context, the ventricular arrhythmia mechanism related to Cav3 mutations may be a combined mechanism: Purkinje cell-generated DADs are able to overcome an anticipated source-sink mismatch because the myocytes (sink) are EAD susceptible, decreasing the arrhythmia threshold and number of required Purkinje cells (source) to initiate a sustained arrhythmia. This proposed model, while only speculative and warranting further theoretical and experimental testing, 51, 52 is akin to Purkinje-dependent DAD perpetuation in EAD-susceptible myocytes in heart failure. Development of an in vivo model to help address and answer these questions of arrhythmogenesis is an area of active investigation in our laboratory.
CONCLUSIONS
Cav3 is an important regulator of ion channel function, and here we provide detailed analysis of the interaction with Kir2.x isoforms, domains, and CBM for interaction, as well as integration of these findings into myocyte and Purkinje modeling system to identify a putative arrhythmia mechanism, which warrants future validation in an in vivo model. Unique from other LQTS, patients with LQT9 might be vulnerable to ventricular arrhythmias because of Purkinje-dependent DAD-triggered activity, which may perpetuate because of altered repolarization reserve in ventricular myocytes.
